Cargando…

Hematopoietic Cell Transplantation for Sickle Cell Disease

Sickle cell disease (SCD) is a severe autosomal recessively inherited disorder of the red blood cell characterized by erythrocyte deformation caused by the polymerization of the abnormal hemoglobin, which leads to erythrocyte deformation and triggers downstream pathological changes. These include ab...

Descripción completa

Detalles Bibliográficos
Autor principal:	Krishnamurti, Lakshmanan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813811/ https://www.ncbi.nlm.nih.gov/pubmed/33469520 http://dx.doi.org/10.3389/fped.2020.551170

Ejemplares similares

Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease
por: Sinha, Cynthia B., et al.
Publicado: (2020)

Sex and frequency of pain episodes are associated with acute pain trajectories in adolescents with sickle cell disease
por: Astles, Rachel, et al.
Publicado: (2023)

A Decision Support Tool for Allogeneic Hematopoietic Stem Cell Transplantation for Children With Sickle Cell Disease: Acceptability and Usability Study
por: Veludhandi, Anirudh, et al.
Publicado: (2021)

Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2023)

Acute Chest Syndrome in Children with Sickle Cell Disease
por: Jain, Shilpa, et al.
Publicado: (2017)

The perception of pediatric sickle cell anemia patient's caregivers toward hematopoietic stem cell transplantation (single-center experience, Saudi Arabia)
por: Monagel, Dania A., et al.
Publicado: (2023)

Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation
por: Stenger, Elizabeth O., et al.
Publicado: (2015)

Assessing Patient Preferences for Treatment Options for Pediatric Sickle Cell Disease: A Critical Review of Quantitative and Qualitative Studies
por: Katoch, Deeksha, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
por: Gennery, Andrew R., et al.
Publicado: (2019)

Case Report: Liver as a Source of Hematopoietic Stem Cells After Liver Transplantation Following Hematopoietic Stem Cell Transplantation
por: Jarmoliński, Tomasz, et al.
Publicado: (2022)

T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy
por: Takahashi, Takuto, et al.
Publicado: (2022)

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study
por: Krishnamurti, Lakshmanan, et al.
Publicado: (2022)

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant Patients
por: Neely, Jessica A., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplant for the Treatment of X-MAID
por: Henrickson, Sarah E., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism
por: Tan, Emily Y., et al.
Publicado: (2019)

Hematopoietic Cell Transplantation for MHC Class II Deficiency
por: Lum, Su Han, et al.
Publicado: (2019)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
por: Katsanis, Emmanuel, et al.
Publicado: (2022)

Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
por: Chiang, Kate Chander, et al.
Publicado: (2023)

Presence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives
por: Castagnoli, Riccardo, et al.
Publicado: (2019)

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2018)

Effects of Hematopoietic Cell Transplantation on the Pulmonary Immune Response to Infection
por: Zinter, Matt S., et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
por: Haddad, Elie, et al.
Publicado: (2019)

Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the Pain in Sickle Cell Epidemiology Study
por: Bakshi, Nitya, et al.
Publicado: (2022)

Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision
por: Creary, Susan, et al.
Publicado: (2015)

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2017)

Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT
por: Neven, Benedicte, et al.
Publicado: (2020)

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022)

Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode
por: Bakshi, Nitya, et al.
Publicado: (2018)

Prevalence and predictors of chronic pain intensity and disability among adults with sickle cell disease
por: Matthie, Nadine, et al.
Publicado: (2020)

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
por: Sinha, Cynthia B., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for the Treatment of Epstein-Barr Virus-Associated T- or NK-Cell Lymphoproliferative Diseases and Associated Disorders
por: Sawada, Akihisa, et al.
Publicado: (2018)

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
por: Arnold, Staci D., et al.
Publicado: (2017)

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study
por: Bakshi, Nitya, et al.
Publicado: (2020)

A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key
por: Ferdjallah, Asmaa, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease
por: Saraf, Santosh L., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplantation for DNA Double Strand Breakage Repair Disorders
por: Wolska-Kuśnierz, Beata, et al.
Publicado: (2020)

From trust to skepticism: An in-depth analysis across age groups of adults with sickle cell disease on their perspectives regarding hydroxyurea
por: Sinha, Cynthia B., et al.
Publicado: (2018)

Genome editing for sickle cell disease: still time to correct?
por: Ceglie, Giulia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gdhacelqkd4gkahdf90bak0u0j